Saúde
Planning pregnancy while using GLP-1 medications? Here's what research shows about timing, safety guidelines, and conception success.
Most GLP-1 side effects are manageable, but knowing which symptoms cross the line from common to concerning can make all the difference. Here's what clinical data says about when to reach out for help.
Scientists are looking beyond the scale at how GLP-1 drugs might affect the biology of aging itself. Here is what the evidence actually shows so far.
GLP-1 medications have transformed obesity treatment but remain largely inaccessible through public healthcare. Brazil's SUS approved semaglutide yet still doesn't offer it. Here's why.
Proper disposal of Ozempic, Wegovy, and Mounjaro pens protects your family, sanitation workers, and the environment. Here's everything you need to know.
Combining alcohol with GLP-1 weight loss pens raises practical questions for many people on treatment. Here's what current medical guidance and pharmacology tell us.
GLP-1 medications like Ozempic and Mounjaro show promise for heart health, but patients with cardiac conditions need special consideration. Here's what cardiologists actually evaluate before prescribing.
Rapid weight loss from semaglutida and tirzepatida can affect your skin in ways worth understanding. Here's what the evidence says about loose skin, dryness, and other dermatological changes.
Starting Ozempic or Mounjaro means reviewing your entire medication list. Here is what clinical guidance tells us about drug interactions with GLP-1 agonists and how to stay safe.
GLP-1 medications like Ozempic and Wegovy may affect sexual desire, but the relationship is more complex than you might think. Here's what research actually shows.
